Background Image
Table of Contents Table of Contents
Previous Page  45 / 102 Next Page
Information
Show Menu
Previous Page 45 / 102 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 3, May/June 2016

AFRICA

167

The endothelium is involved in the beneficial vascular action

of the glitazones.

21

Various authors have shown that pioglitazone

directly dilates blood vessels by blocking the calcium channels.

11,22

It has been reported that a decrease in blood pressure due to

pioglitazone is due to direct dilation of the vascular smooth

muscles by blocking the calcium channels or reducing total

peripheral resistance.

11,22,23

In vivo

PPAR-alpha and -gamma agonists have been shown

to reduce superoxide generation, restore endothelial dysfunction

and improve vasorelaxation to acetyl choline in the aorta of

diabetic rats.

10,24

Majithiya and colleagues reported that treatment

with pioglitazone reduced blood pressure, reduced oxidative

stress and restored endothelial function in STZ-induced diabetic

rats. The fact that pioglitazone reduced oxidative stress may have

been a cause of the reduction in blood pressure.

The protective effect of pioglitazone against oxidative stress

may prevent the breakdown of NO, which may improve vascular

function. Similar observations were made by Bagi and co-workers

that pioglitazone increased NO bio-availability and reduced

oxidative stress in coronary arterioles of mice with type 2 diabetes.

25

Matsumoto and colleagues reported that chronic treatment with

pioglitazone restored impaired NO-mediated, endothelium-

dependent relaxation in diabetic rat aortae.

26

It has been shown that

reduction in blood pressure in the case of STZ-induced diabetic rats

was NO mediated.

4

Calnek and co-workers reported that PPAR-

gamma agonists increased NO bioavailability in cultured cells.

27

Pioglitazone was shown to directly induce a relaxation

of rat aortae pre-contracted with phenylephrine, which was

inhibited by L-NAME.

10

Similarly, indomethacin-treated vessels

incubated with pioglitazone markedly reduced the phenylephrine

contractions.

3

Although most researchers agree that the

sensitivity to phenylephrine was unchanged during the early

stage of diabetes (up to 12 weeks in STZ-induced diabetic rats),

they disagree on the response to phenylephrine. Agrawal and

McNeill reported an increase in contractility in response to

phenylephrine,

28

Pfaffman and co-workers reported a decrease,

29

and Scarborough and Carrier and White and Carrier reported

no change.

30,31

In contrast, studies that extended the diabetic

duration up to 43–52 weeks have demonstrated a consistent

increase in sensitivity to noradrenaline in rat aortae

32

and

mesenteric arteries

33

from STZ-induced diabetic rats.

-log M Clonidine

9

8

7

6

5

4

Contraction (mg)

400

300

200

100

0

–100

Cont

Pio

Los

Pio + Los

**

*

Fig. 6.

Effects of pioglitazone and losartan on the response of

aortic segments to increasing concentrations of cloni-

dine in the HT group. Cont: control, Pio: pioglitazone,

Los: losartan, Pio

+

Los: pioglitazone

+

losartan. Values

are expressed as mean

±

SEM (

n

=

5). *Cont vs Pio

(

p

=

0.004); *Cont Clo vs Los (

p

=

0.014); *Cont Clo vs

Pio

+

Los (

p

=

0.001).

-log M Clonidine

9

8

7

6

5

4

Contraction (mg)

400

300

200

100

0

–100

–200

–300

–400

Cont

Pio

Los

Pio + Los

#

*

*

Fig. 5.

Effects of pioglitazone and losartan on the response of

aortic segments to increasing concentrations of cloni-

dine in the control group. Cont: control, Pio: pioglita-

zone, Los: losartan, Pio

+

Los: pioglitazone

+

losartan.

Values are expressed as mean

±

SEM (

n

=

14). *Cont

vs Pio (

p

=

0.001); *Cont vs Los (

p

=

0.011);

#

Cont vs

Pio

+

Los (

p

<

0.001).

*

-log M Clonidine

9

8

7

6

5

4

Contraction (mg)

400

300

200

100

0

Cont

Pio

Los

Pio + Los

Fig. 7.

Effects of pioglitazone and losartan on the response of

aortic segments to increasing concentrations of cloni-

dine in DM group. Cont: control, Pio: pioglitazone, Los:

losartan, Pio

+

Los: pioglitazone

+

losartan. Values are

expressed as mean

±

SEM (

n

=

16). *Cont vs Pio

+

Los

(

p

=

0.005).

-log M Clonidine

9

8

7

6

5

4

Contraction (mg)

400

300

200

100

0

–100

Cont

Pio

Los

Pio + Los

Fig. 8.

Effects of pioglitazone and losartan on the response of

aortic segments to increasing concentrations of cloni-

dine in the HT

+

DM group. Cont: control, Pio: pioglita-

zone, Los: losartan, Pio

+

Los: pioglitazone

+

losartan.

Values are expressed as mean

±

SEM (

n

=

13).